← 產業報告目錄

Healthcare Market Research Report by Product (Pharmaceuticals, Medical Devices, Dietary Supplements, Personal Care Products, Homeopathic Products), by Product and Application (Pharmaceuticals (Allergy, Dermatology, Digestive Health, Gynecology, Ophthalmology, Pain Management, Stress / Sleep Care, Winter Illness, Mother & Baby Care, Others), Medical Devices (Allergy, Dermatology, Digestive Health, Gynecology, Ophthalmology, Pain Management, Stress / Sleep Care, Winter Illness, Mother & Baby Care, Others), Dietary Supplements (Allergy, Dermatology, Digestive Health, Gynecology, Ophthalmology, Pain Management, Stress / Sleep Care, Winter Illness, Mother & Baby Care Others), Personal Care Products (Allergy, Dermatology, Digestive Health, Gynecology, Ophthalmology, Pain Management, Stress / Sleep Care, Winter Illness, Mother & Baby Care, Others), Homeopathic Products (Allergy, Dermatology, Digestive Health, Gynecology, Ophthalmology, Pain Management, Stress / Sleep Care, Winter Illness, Mother & Baby Care, Others)], by Category and Product [RX (Pharmaceuticals, Medical Devices, Dietary Supplements, Personal Care Products, Homeopathic Products), OTC (Pharmaceuticals, Medical Devices, Dietary Supplements, Personal Care Products, Homeopathic Products)], by Application [Allergy (Respiratory Allergy, Food Allergy, Skin Allergy, Drug Allergy, Others), Dermatology (Psoriasis, Atopic Dermatitis, Alopecia, Others), Digestive Health (Irritable Bowel Syndrome (IBS), Inflammatory Bowel Disease, GERD, Peptic Ulcer, Others), Gynecology (STD, Menstrual Disorders, Fertility / Reproductive Health, Others), Ophthalmology (Cataract, Glaucoma, Age-related macular degeneration (AMD), Diabetic Retinopathy, Others), Pain Management (Acute Pain, Chronic Pain), Stress / Sleep Care (Stress, Sleep Initiation, Insomnia, Combined Stress + Sleep Interventions) Winter Illness (Flu, Common Cold, Cough, Sore Throat, Fever, Others), Mother & Baby Care (Prenatal, Labor, Neonatal / Newborn Care, Others), Others), by Application and Galenic Forms [Allergy (Tablets and Capsules, Liquids and Syrups, Nasal Sprays and Inhalers, Topical Creams, Others), Dermatology (Topical Creams, Gels and Lotions, Tablets and Capsules, Others), Digestive Health (Tablets and Capsules, Liquids and Syrups, Powders, Others), Gynecology (Tablets and Capsules, Creams / Gels Copyright, Others), Ophthalmology (Eye Drops, Ointments, Others), Pain Management (Tablets and Capsules, Liquids, Topical Creams, Others), Stress / Sleep Care (Tablets and Capsules, Liquids and Syrups, Others), Winter Illness (Tablets and Capsules, Liquids and Syrups, Nasal Sprays and Inhalers, Topical Rubs / Balms, Others), Mother & Baby Care (Tablets and Capsules, Liquids and Syrups, Topical Creams, Others) Others], and by Application and Galenic Forms [Retail Pharmacies, Online Channels (Online Pharmacies, Ecommerce, Brand Websites), Other Channels] Forecast till 2035

出版商 Market Research Future產業別 Healthcare & Life Sciences出版日期 2026-02-07頁數 276報告編號 MRFRHC3000CR200

授權報價

Single User Price$4,950 USD
Multi User Licence (up to 10 users)$5,950 USD
Enterprisewide Price (Global Site License)$7,250 USD
洽詢購買 申請 Sample

報告摘要

The Global Healthcare Market was valued at USD 3,075.69 billion in 2024 and is projected to reach USD 8,826.38 billion by 2035. The market is expected to expand at a compound annual growth rate (CAGR) of 10.04% during the forecast period from 2025 to 2035. Expanding Elderly Population Driving Healthcare Demand The world's population is getting older fast, and this is a big reason why the healthcare market is growing so quickly. Older people need to see doctors more often and take medicine for a long time to manage diseases like heart problems, diabetes, and Alzheimer's. As more people aged 60, hospitals, medicine, online health services, and care for older people are in higher demand. Detailed Segmentation Analysis of the Global Healthcare Market By Product • Pharmaceuticals: Dominant category providing therapeutic drug treatments. • Medical Devices: Equipment supporting clinical monitoring and treatment. • Dietary Supplements: Nutrient-based products improving preventive healthcare. • Personal Care Products: Consumer products supporting hygiene and wellness. • Homeopathic Products: Herbal-based remedies used in alternative medicine. By Product and Application • Pharmaceuticals: Drug therapies covering multiple healthcare conditions. • Medical Devices: Devices assisting medical diagnosis and treatment. • Dietary Supplements: Nutrition products enhancing patient recovery support. • Personal Care Products: Wellness items promoting preventive healthcare routines. • Homeopathic Products: Natural solutions supporting holistic medical care. By Category and Product • RX: Prescription medicines regulated under healthcare authorities. • OTC: Consumer healthcare products available without prescriptions. By Application • Allergy: Solutions targeting respiratory and skin allergy conditions. • Dermatology: Treatments addressing skin disease and cosmetic concerns. • Digestive Health: Gastrointestinal treatments improving digestion and metabolism. • Gynecology: Products supporting reproductive and hormonal health. • Ophthalmology: Therapies preventing and treating eye disorders. • Pain Management: Medicines reducing acute and chronic pain. • Stress / Sleep Care: Healthcare products improving sleep quality. • Winter Illness: Medicines treating cold, cough, and flu. • Mother & Baby Care: Specialized care products for mothers and infants. • Others: Additional healthcare treatments across specialized fields. By Application and Galenic Forms • Allergy: Tablets, sprays, and topical allergy relief. • Dermatology: Creams, lotions, and capsules for skin. • Digestive Health: Capsules, syrups, powders supporting digestion. • Gynecology: Tablets, gels, creams supporting reproductive care. • Ophthalmology: Eye drops and ointments for vision care. • Pain Management: Tablets, liquids, and topical pain formulations. • Stress / Sleep Care: Capsules and syrups improving sleep cycles. • Winter Illness: Tablets, syrups, sprays treating seasonal illnesses. • Mother & Baby Care: Gentle formulations supporting maternal health. • Others: Various dosage forms addressing niche healthcare needs. By Distribution Channel • Retail Pharmacies: Major physical outlets selling healthcare products. • Online Channels: Digital marketplaces enabling convenient medicine access. • Other Channels: Institutional and specialty healthcare distribution channels. Regional Market Overview In North America, people are buying a lot of medicine and using digital health tools, which is making the healthcare market bigger. Europe is also growing, but not as fast, because people are taking care of themselves more and using over-the-counter health products. However, countries in Asia and Latin America are growing faster because they are using digital health tools, changing rules, and people are taking care of themselves more. Marketing and Consumer Engagement Initiative Some companies are working together to make new products. For example, Procter & Gamble made a new line of skincare and personal care products with Universal Pictures. They want to get people excited about their products by working with popular brands. The healthcare market is changing a lot because of new technologies like artificial intelligence, machine learning, and digital health tools. Technological Transformation Enhancing Healthcare Delivery The healthcare market is growing and changing quickly, and new technologies are making a big difference. As the world's population gets older, it's likely that the demand for healthcare will keep growing, and companies will need to find new ways to meet this demand. Key Report Attributes • Market Size 2024: USD 3,075.69 Billion • Market Size 2035: USD 8,826.38 Billion • CAGR (2025-2035): 10.04% • Base Year: 2024 • Market Forecast Period: 2025-2035 Industry Segmentations Growth • By Product: Pharmaceuticals - 10.10%, Medical Devices - 11.31%. • By Application: Allergy - 9.09%, Dermatology - 9.67%. • By Distribution Channel: Retail Pharmacies - 10.28%, Online Channels - 11.72%.
目錄 Table of Contents
TABLE OF CONTENTS 1 EXECUTIVE SUMMARY ...... 19 2 MARKET INTRODUCTION ........ 21 2.1 DEFINITION ...... 21 2.2 SCOPE OF THE STUDY ...... 21 2.3 RESEARCH OBJECTIVE ........ 21 2.4 MARKET STRUCTURE ...... 22 3 RESEARCH METHODOLOGY ...... 29 3.1 OVERVIEW ........ 29 3.2 DATA FLOW ...... 31 3.2.1 DATA MINING PROCESS ......... 31 3.3 PURCHASED DATABASE: ......... 32 3.4 SECONDARY SOURCES: ........ 33 3.4.1 SECONDARY RESEARCH DATA FLOW: ......... 34 3.5 PRIMARY RESEARCH: ....... 35 3.5.1 PRIMARY RESEARCH DATA FLOW: ......... 36 3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED ......... 37 3.5.3 PRIMARY RESEARCH: REGIONAL COVERAGE ...... 37 3.6 APPROACHES FOR MARKET SIZE ESTIMATION: ....... 38 3.6.1 REVENUE ANALYSIS APPROACH ......... 38 3.7 DATA FORECASTING......... 39 3.7.1 DATA FORECASTING TYPE ...... 39 3.8 DATA MODELING ........ 40 3.8.1 MICROECONOMIC FACTOR ANALYSIS: ........ 40 3.8.2 DATA MODELING: ....... 41 3.9 TEAMS AND ANALYST CONTRIBUTION ....... 43 4 MARKET DYNAMICS ........ 45 4.1 INTRODUCTION ....... 45 4.2 DRIVERS ......... 46 4.2.1 RISING AGING POPULATION ....... 46 4.2.2 ADVANCEMENTS IN MEDICAL TECHNOLOGY ...... 46 4.2.3 RISING PREVALENCE OF CHRONIC DISEASES ...... 47 4.2.4 INCREASED HEALTHCARE EXPENDITURE ........ 47 4.3 RESTRAINTS ........ 49 4.3.1 HIGH COST OF HEALTHCARE SERVICES ...... 49 4.3.2 STRINGENT REGULATORY COMPLIANCE ......... 49 4.3.3 DATA PRIVACY AND SECURITY CONCERNS ......... 49 4.4 OPPORTUNITIES ......... 51 4.4.1 PERSONALIZED MEDICINE ...... 51 4.4.2 HEALTHCARE DATA ANALYTICS ......... 51 4.4.3 EMERGING MARKETS PENETRATION ....... 52 5 INDUSTRY TREND ANALYSIS ......... 53 5.1 REGULATORY ENVIRONMENT & COMPLIANCE ......... 53 5.2 MARKET TRENDS & INNOVATION ...... 56 5.3 PATIENT DEMOGRAPHICS & DISEASE BURDENS ....... 57 5.3.1 DERMATOLOGY ...... 57 5.3.2 DIGESTIVE HEALTH ........ 57 5.3.3 GYNECOLOGY ........ 58 5.3.4 OPHTHALMOLOGY ......... 58 5.4 PRICING ANALYSIS & REIMBURSEMENT DYNAMICS ...... 59 5.4.1 PRICING ANALYSIS ......... 59 5.4.1.1 NORTH AMERICA ....... 59 5.4.1.1.1 NORTH AMERICA PRICING ANALYSIS, BY PRODUCT ....... 59 5.4.1.2 EUROPE ......... 60 5.4.1.2.1 EUROPE PRICING ANALYSIS, BY PRODUCT......... 60 5.4.1.3 REST OF THE WORLD ...... 61 5.4.1.3.1 REST OF THE WORLD PRICING ANALYSIS, BY PRODUCT ......... 61 5.4.2 REIMBURSEMENT DYNAMICS ......... 62 5.5 MARKET ENTRY & EXIT BARRIERS ........ 63 5.5.1 BARRIERS TO ENTRY ...... 63 5.5.2 BARRIERS TO EXIT ...... 63 5.6 PARTNERSHIPS & COLLABORATIONS ........ 63 5.7 PESTLE ANALYSIS ......... 64 5.7.1 POLITICAL FACTORS ...... 64 5.7.2 ECONOMIC FACTORS ......... 65 5.7.3 SOCIAL FACTORS ....... 65 5.7.4 TECHNOLOGICAL FACTORS ........ 65 5.7.5 LEGAL FACTORS ........ 65 5.7.6 ENVIRONMENTAL FACTORS ....... 66 5.8 PORTER'S FIVE FORCES MODEL ....... 67 5.8.1 THREAT OF NEW ENTRANTS ....... 67 5.8.2 BARGAINING POWER OF SUPPLIERS ....... 67 5.8.3 THREAT OF SUBSTITUTES ...... 68 5.8.4 BARGAINING POWER OF BUYERS ........ 68 5.8.5 INTENSITY OF RIVALRY ...... 68 5.9 CASE STUDY ANALYSIS ...... 68 5.10 INVESTMENT & FUNDING SCENARIOS ...... 69 5.11 POST-MARKET SURVEILLANCE & SAFETY DATA ........ 69 6 GLOBAL HEALTHCARE MARKET, BY PRODUCT ....... 72 6.1 OVERVIEW ........ 72 7 GLOBAL HEALTHCARE MARKET, BY PRODUCT AND APPLICATION ...... 76 7.1 OVERVIEW ........ 76 8 GLOBAL HEALTHCARE MARKET, BY CATEGORY AND PRODUCT ...... 80 8.1 OVERVIEW ........ 80 9 GLOBAL HEALTHCARE MARKET, BY APPLICATION ......... 83 9.1 OVERVIEW ........ 83 10 GLOBAL HEALTHCARE MARKET, BY APPLICATION AND GALENIC FORMS ...... 92 10.1 OVERVIEW ........ 92 11 GLOBAL HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL...... 95 11.1 OVERVIEW ........ 95 12 GLOBAL HEALTHCARE MARKET, BY REGION ...... 98 12.1 OVERVIEW ........ 98 12.2 NORTH AMERICA ....... 100 12.2.1 US...... 108 12.2.2 CANADA ........ 114 12.3 EUROPE ...... 120 12.3.1 FRANCE ......... 128 12.3.2 ITALY ......... 134 12.3.3 SPAIN ........ 140 12.3.4 BELGIUM ........ 145 12.3.5 BULGARIA ...... 150 12.3.6 ROMANIA ....... 156 12.3.7 CZECH REPUBLIC ....... 161 12.3.8 SLOVAKIA ...... 166 12.3.9 HUNGARY ...... 172 12.3.10 RUSSIA ...... 178 12.3.11 REST OF EUROPE ........ 184 12.4 REST OF THE WORLD ........ 190 12.4.1 CHINA ........ 198 12.4.2 COLOMBIA ......... 204 12.4.3 BRAZIL ....... 210 12.4.4 REST OF THE WORLD COUNTRIES ....... 216 13 COMPETITIVE LANDSCAPE ........ 224 13.1 INTRODUCTION ....... 224 13.2 MARKET SHARE ANALYSIS, 2024 ....... 224 13.3 COMPETITOR DASHBOARD......... 225 13.4 PUBLIC PLAYERS STOCK SUMMARY ......... 226 13.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANCIAL ...... 226 13.6 KEY DEVELOPMENTS & GROWTH STRATEGIES ........ 226 13.6.1 PRODUCT LAUNCH ......... 226 13.6.2 ACQUISITION ......... 228 13.6.3 COLLABORATION/ PARTNERSHIP ....... 229 13.6.4 FACILITY EXPANSION ......... 229 14 COMPANY PROFILE ........ 230 14.1 PROCTER & GAMBLE ......... 230 14.1.1 COMPANY OVERVIEW ......... 230 14.1.2 FINANCIAL OVERVIEW ........ 231 14.1.3 PRODUCTS OFFERED ...... 232 14.1.4 KEY DEVELOPMENTS ...... 235 14.1.5 SWOT ANALYSIS ........ 235 14.1.6 KEY STRATEGIES ........ 236 14.2 RECKITT BENCKISER GROUP PLC ........ 237 14.2.1 COMPANY OVERVIEW ......... 237 14.2.2 FINANCIAL OVERVIEW ........ 238 14.2.3 PRODUCTS OFFERED ...... 239 14.2.4 KEY DEVELOPMENTS ...... 240 14.2.5 SWOT ANALYSIS ........ 241 14.2.6 KEY STRATEGIES ........ 241 14.3 ABBOTT ...... 242 14.3.1 COMPANY OVERVIEW ......... 242 14.3.2 FINANCIAL OVERVIEW ........ 243 14.3.3 PRODUCTS OFFERED ...... 243 14.3.4 KEY DEVELOPMENTS ...... 246 14.3.5 KEY STRATEGIES ........ 247 14.4 BOIRON LABORATORIES ...... 248 14.4.1 COMPANY OVERVIEW ......... 248 14.4.2 FINANCIAL OVERVIEW ........ 249 14.4.3 PRODUCTS OFFERED ...... 250 14.4.4 KEY DEVELOPMENTS ...... 252 14.4.5 KEY STRATEGIES ........ 252 14.5 GNC HOLDINGS, LLC ....... 253 14.5.1 COMPANY OVERVIEW ......... 253 14.5.2 FINANCIAL OVERVIEW ........ 253 14.5.3 PRODUCTS OFFERED ...... 254 14.5.4 KEY DEVELOPMENTS ...... 254 14.5.5 KEY STRATEGIES ........ 254 14.6 BAYER AG ......... 255 14.6.1 COMPANY OVERVIEW ......... 255 14.6.2 FINANCIAL OVERVIEW ........ 256 14.6.3 PRODUCTS OFFERED ...... 257 14.6.4 KEY DEVELOPMENTS ...... 258 14.6.5 SWOT ANALYSIS ........ 259 14.6.6 KEY STRATEGY ....... 259 14.7 JOHNSON & JOHNSON INC. ......... 260 14.7.1 COMPANY OVERVIEW ......... 260 14.7.2 FINANCIAL OVERVIEW ........ 261 14.7.3 PRODUCTS OFFERED ...... 262 14.7.4 KEY DEVELOPMENTS ...... 263 14.7.5 KEY STRATEGIES ........ 263 14.8 UNILEVER ......... 264 14.8.1 COMPANY OVERVIEW ......... 264 14.8.2 FINANCIAL OVERVIEW ........ 265 14.8.3 PRODUCTS OFFERED ...... 266 14.8.4 KEY DEVELOPMENTS ...... 266 14.8.5 SWOT ANALYSIS ........ 267 14.8.6 KEY STRATEGIES ........ 267 14.9 NESTLÉ ...... 268 14.9.1 COMPANY OVERVIEW ......... 268 14.9.2 FINANCIAL OVERVIEW ........ 269 14.9.3 PRODUCTS OFFERED ...... 270 14.9.4 KEY DEVELOPMENTS ...... 270 14.9.5 KEY STRATEGIES ........ 270 14.10 HALEON PLC ........ 271 14.10.1 COMPANY OVERVIEW ......... 271 14.10.2 FINANCIAL OVERVIEW ........ 272 14.10.3 PRODUCTS OFFERED ...... 273 14.10.4 KEY DEVELOPMENTS ...... 273 14.10.5 SWOT ANALYSIS ........ 274 14.10.6 KEY STRATEGIES ........ 274 15 DATA CITATIONS ......... 275
圖表清單 List of Tables & Figures
LIST OF TABLES TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT 42 TABLE 2 NORTH AMERICA PRICING ANALYSIS, BY PRODUCT, 2024 (USD) 59 TABLE 3 EUROPE PRICING ANALYSIS, BY PRODUCT, 2024 (USD) 60 TABLE 4 REST OF THE WORLD PRICING ANALYSIS, BY PRODUCT, 2024 (USD) 61 TABLE 5 GLOBAL HEALTHCARE MARKET, BY PRODUCT, 2019–2035 (USD BILLION) 74 TABLE 6 GLOBAL HEALTHCARE MARKET, BY PRODUCT, 2019–2035 (VOLUME IN BILLION UNITS) 74 TABLE 7 GLOBAL HEALTHCARE MARKET, BY APPLICATION, 2019–2035 (USD BILLION) 87 TABLE 8 GLOBAL HEALTHCARE MARKET, BY APPLICATION, 2019–2035 (VOLUME IN BILLION UNITS) 89 TABLE 9 GLOBAL HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2019–2035 (USD BILLION) 96 TABLE 10 GLOBAL HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2019–2035 (VOLUME IN BILLION UNITS) 97 TABLE 11 GLOBAL HEALTHCARE MARKET, BY REGION, 2019-2035 (USD BILLION) 98 TABLE 12 GLOBAL HEALTHCARE MARKET, BY REGION, 2019-2035 (VOLUME IN BILLION UNITS) 99 TABLE 13 NORTH AMERICA: HEALTHCARE MARKET, BY COUNTRY, 2019-2035 (USD BILLION) 101 TABLE 14 NORTH AMERICA: HEALTHCARE MARKET, BY COUNTRY, 2019-2035 (VOLUME IN BILLION UNITS) 102 TABLE 15 NORTH AMERICA: HEALTHCARE MARKET, BY PRODUCT, 2019–2035 (USD BILLION) 102 TABLE 16 NORTH AMERICA: HEALTHCARE MARKET, BY PRODUCT, 2019–2035 (VOLUME IN BILLION UNITS) 103 TABLE 17 NORTH AMERICA: HEALTHCARE MARKET, BY APPLICATION, 2019–2035 (USD BILLION) 103 TABLE 18 NORTH AMERICA: HEALTHCARE MARKET, BY APPLICATION, 2019–2035 (VOLUME IN BILLION UNITS) 105 TABLE 19 NORTH AMERICA: HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2019–2035 (USD BILLION) 107 TABLE 20 NORTH AMERICA: HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2019–2035 (VOLUME IN BILLION UNITS) 107 TABLE 21 US: HEALTHCARE MARKET, BY PRODUCT, 2019–2035 (USD BILLION) 108 TABLE 22 US: HEALTHCARE MARKET, BY PRODUCT, 2019–2035 (VOLUME IN BILLION UNITS) 108 TABLE 23 US: HEALTHCARE MARKET, BY APPLICATION, 2019–2035 (USD BILLION) 108 TABLE 24 US: HEALTHCARE MARKET, BY APPLICATION, 2019–2035 (VOLUME IN BILLION UNITS) 111 TABLE 25 US: HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2019–2035 (USD BILLION) 113 TABLE 26 US: HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2019–2035 (VOLUME IN BILLION UNITS) 113 TABLE 27 CANADA: HEALTHCARE MARKET, BY PRODUCT, 2019–2035 (USD BILLION) 114 TABLE 28 CANADA: HEALTHCARE MARKET, BY PRODUCT, 2019–2035 (VOLUME IN BILLION UNITS) 114 TABLE 29 CANADA: HEALTHCARE MARKET, BY APPLICATION, 2019–2035 (USD BILLION) 114 TABLE 30 CANADA: HEALTHCARE MARKET, BY APPLICATION, 2019–2035 (VOLUME IN BILLION UNITS) 116 TABLE 31 CANADA: HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2019–2035 (USD BILLION) 118 TABLE 32 CANADA: HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2019–2035 (VOLUME IN BILLION UNITS) 119 TABLE 33 EUROPE HEALTHCARE MARKET, BY REGION, 2019-2035 (USD BILLION) 121 TABLE 34 EUROPE HEALTHCARE MARKET, BY REGION, 2019-2035 (USD BILLION) 122 TABLE 35 EUROPE: HEALTHCARE MARKET, BY PRODUCT, 2019–2035 (USD BILLION) 122 TABLE 36 EUROPE: HEALTHCARE MARKET, BY PRODUCT, 2019–2035 (VOLUME IN BILLION UNITS) 122 TABLE 37 EUROPE: HEALTHCARE MARKET, BY APPLICATION, 2019–2035 (USD BILLION) 123 TABLE 38 EUROPE: HEALTHCARE MARKET, BY APPLICATION, 2019–2035 (VOLUME IN BILLION UNITS) 125 TABLE 39 EUROPE: HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2019–2035 (USD BILLION) 127 TABLE 40 EUROPE: HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2019–2035 (VOLUME IN BILLION UNITS) 127 TABLE 41 FRANCE: HEALTHCARE MARKET, BY PRODUCT, 2019–2035 (USD BILLION) 128 TABLE 42 FRANCE: HEALTHCARE MARKET, BY PRODUCT, 2019–2035 (VOLUME IN BILLION UNITS) 129 TABLE 43 FRANCE: HEALTHCARE MARKET, BY APPLICATION, 2019–2035 (USD BILLION) 129 TABLE 44 FRANCE: HEALTHCARE MARKET, BY APPLICATION, 2019–2035 (VOLUME IN BILLION UNITS) 132 TABLE 45 FRANCE: HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2019–2035 (USD BILLION) 133 TABLE 46 FRANCE: HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2019–2035 (VOLUME IN BILLION UNITS) 134 TABLE 47 ITALY: HEALTHCARE MARKET, BY PRODUCT, 2019–2035 (USD BILLION) 134 TABLE 48 ITALY: HEALTHCARE MARKET, BY PRODUCT, 2019–2035 (VOLUME IN BILLION UNITS) 135 TABLE 49 ITALY: HEALTHCARE MARKET, BY APPLICATION, 2019–2035 (USD BILLION) 135 TABLE 50 ITALY: HEALTHCARE MARKET, BY APPLICATION, 2019–2035 (VOLUME IN BILLION UNITS) 137 TABLE 51 ITALY: HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2019–2035 (USD BILLION) 139 TABLE 52 ITALY: HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2019–2035 (VOLUME IN BILLION UNITS) 139 TABLE 53 SPAIN: HEALTHCARE MARKET, BY PRODUCT, 2019–2035 (USD BILLION) 140 TABLE 54 SPAIN: HEALTHCARE MARKET, BY PRODUCT, 2019–2035 (VOLUME IN BILLION UNITS) 140 TABLE 55 SPAIN: HEALTHCARE MARKET, BY APPLICATION, 2019–2035 (USD BILLION) 140 TABLE 56 SPAIN: HEALTHCARE MARKET, BY APPLICATION, 2019–2035 (VOLUME IN BILLION UNITS) 142 TABLE 57 SPAIN: HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2019–2035 (USD BILLION) 144 TABLE 58 SPAIN: HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2019–2035 (VOLUME IN BILLION UNITS) 144 TABLE 59 BELGIUM: HEALTHCARE MARKET, BY PRODUCT, 2019–2035 (USD BILLION) 145 TABLE 60 BELGIUM: HEALTHCARE MARKET, BY PRODUCT, 2019–2035 (VOLUME IN BILLION UNITS) 145 TABLE 61 BELGIUM: HEALTHCARE MARKET, BY APPLICATION, 2019–2035 (USD BILLION) 146 TABLE 62 BELGIUM: HEALTHCARE MARKET, BY APPLICATION, 2019–2035 (VOLUME IN BILLION UNITS) 147 TABLE 63 BELGIUM: HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2019–2035 (USD BILLION) 149 TABLE 64 BELGIUM: HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2019–2035 (VOLUME IN BILLION UNITS) 150 TABLE 65 BULGARIA: HEALTHCARE MARKET, BY PRODUCT, 2019–2035 (USD BILLION) 150 TABLE 66 BULGARIA: HEALTHCARE MARKET, BY PRODUCT, 2019–2035 (VOLUME IN BILLION UNITS) 151 TABLE 67 BULGARIA: HEALTHCARE MARKET, BY APPLICATION, 2019–2035 (USD BILLION) 151 TABLE 68 BULGARIA: HEALTHCARE MARKET, BY APPLICATION, 2019–2035 (VOLUME IN BILLION UNITS) 153 TABLE 69 BULGARIA: HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2019–2035 (USD BILLION) 155 TABLE 70 BULGARIA: HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2019–2035 (VOLUME IN BILLION UNITS) 155 TABLE 71 ROMANIA: HEALTHCARE MARKET, BY PRODUCT, 2019–2035 (USD BILLION) 156 TABLE 72 ROMANIA: HEALTHCARE MARKET, BY PRODUCT, 2019–2035 (VOLUME IN BILLION UNITS) 156 TABLE 73 ROMANIA: HEALTHCARE MARKET, BY APPLICATION, 2019–2035 (USD BILLION) 156 TABLE 74 ROMANIA: HEALTHCARE MARKET, BY APPLICATION, 2019–2035 (VOLUME IN BILLION UNITS) 158 TABLE 75 ROMANIA: HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2019–2035 (USD BILLION) 160 TABLE 76 ROMANIA: HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2019–2035 (VOLUME IN BILLION UNITS) 160 TABLE 77 CZECH REPUBLIC: HEALTHCARE MARKET, BY PRODUCT, 2019–2035 (USD BILLION) 161 TABLE 78 CZECH REPUBLIC: HEALTHCARE MARKET, BY PRODUCT, 2019–2035 (VOLUME IN BILLION UNITS) 161 TABLE 79 CZECH REPUBLIC: HEALTHCARE MARKET, BY APPLICATION, 2019–2035 (USD BILLION) 161 TABLE 80 CZECH REPUBLIC: HEALTHCARE MARKET, BY APPLICATION, 2019–2035 (VOLUME IN BILLION UNITS) 163 TABLE 81 CZECH REPUBLIC: HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2019–2035 (USD BILLION) 165 TABLE 82 CZECH REPUBLIC: HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2019–2035 (VOLUME IN BILLION UNITS) 166 TABLE 83 SLOVAKIA: HEALTHCARE MARKET, BY PRODUCT, 2019–2035 (USD BILLION) 166 TABLE 84 SLOVAKIA: HEALTHCARE MARKET, BY PRODUCT, 2019–2035 (VOLUME IN BILLION UNITS) 167 TABLE 85 SLOVAKIA: HEALTHCARE MARKET, BY APPLICATION, 2019–2035 (USD BILLION) 167 TABLE 86 SLOVAKIA: HEALTHCARE MARKET, BY APPLICATION, 2019–2035 (VOLUME IN BILLION UNITS) 169 TABLE 87 SLOVAKIA: HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2019–2035 (USD BILLION) 171 TABLE 88 SLOVAKIA: HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2019–2035 (VOLUME IN BILLION UNITS) 172 TABLE 89 HUNGARY: HEALTHCARE MARKET, BY PRODUCT, 2019–2035 (USD BILLION) 172 TABLE 90 HUNGARY: HEALTHCARE MARKET, BY PRODUCT, 2019–2035 (VOLUME IN BILLION UNITS) 173 TABLE 91 HUNGARY: HEALTHCARE MARKET, BY APPLICATION, 2019–2035 (USD BILLION) 173 TABLE 92 HUNGARY: HEALTHCARE MARKET, BY APPLICATION, 2019–2035 (VOLUME IN BILLION UNITS) 175 TABLE 93 HUNGARY: HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2019–2035 (USD BILLION) 177 TABLE 94 HUNGARY: HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2019–2035 (VOLUME IN BILLION UNITS) 177 TABLE 95 RUSSIA: HEALTHCARE MARKET, BY PRODUCT, 2019–2035 (USD BILLION) 178 TABLE 96 RUSSIA: HEALTHCARE MARKET, BY PRODUCT, 2019–2035 (VOLUME IN BILLION UNITS) 178 TABLE 97 RUSSIA: HEALTHCARE MARKET, BY APPLICATION, 2019–2035 (USD BILLION) 179 TABLE 98 RUSSIA: HEALTHCARE MARKET, BY APPLICATION, 2019–2035 (VOLUME IN BILLION UNITS) 181 TABLE 99 RUSSIA: HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2019–2035 (USD BILLION) 183 TABLE 100 RUSSIA: HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2019–2035 (VOLUME IN BILLION UNITS) 183 TABLE 101 REST OF EUROPE: HEALTHCARE MARKET, BY PRODUCT, 2019–2035 (USD BILLION) 184 TABLE 102 REST OF EUROPE: HEALTHCARE MARKET, BY PRODUCT, 2019–2035 (VOLUME IN BILLION UNITS) 184 TABLE 103 REST OF EUROPE: HEALTHCARE MARKET, BY APPLICATION, 2019–2035 (USD BILLION) 185 TABLE 104 REST OF EUROPE: HEALTHCARE MARKET, BY APPLICATION, 2019–2035 (VOLUME IN BILLION UNITS) 187 TABLE 105 REST OF EUROPE: HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2019–2035 (USD BILLION) 189 TABLE 106 REST OF EUROPE: HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2019–2035 (VOLUME IN BILLION UNITS) 189 TABLE 107 REST OF THE WORLD: HEALTHCARE MARKET, BY COUNTRY, 2019-2035 (USD BILLION) 191 TABLE 108 REST OF THE WORLD: HEALTHCARE MARKET, BY COUNTRY, 2019-2035 (VOLUME IN BILLION UNITS) 191 TABLE 109 REST OF THE WORLD: HEALTHCARE MARKET, BY PRODUCT, 2019–2035 (USD BILLION) 192 TABLE 110 REST OF THE WORLD: HEALTHCARE MARKET, BY PRODUCT, 2019–2035 (VOLUME IN BILLION UNITS) 192 TABLE 111 REST OF THE WORLD: HEALTHCARE MARKET, BY APPLICATION, 2019–2035 (USD BILLION) 193 TABLE 112 REST OF THE WORLD: HEALTHCARE MARKET, BY APPLICATION, 2019–2035 (VOLUME IN BILLION UNITS) 195 TABLE 113 REST OF THE WORLD: HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2019–2035 (USD BILLION) 197 TABLE 114 REST OF THE WORLD: HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2019–2035 (VOLUME IN BILLION UNITS) 197 TABLE 115 CHINA: HEALTHCARE MARKET, BY PRODUCT, 2019–2035 (USD BILLION) 198 TABLE 116 CHINA: HEALTHCARE MARKET, BY PRODUCT, 2019–2035 (VOLUME IN BILLION UNITS) 198 TABLE 117 CHINA: HEALTHCARE MARKET, BY APPLICATION, 2019–2035 (USD BILLION) 199 TABLE 118 CHINA: HEALTHCARE MARKET, BY APPLICATION, 2019–2035 (VOLUME IN BILLION UNITS) 201 TABLE 119 CHINA: HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2019–2035 (USD BILLION) 203 TABLE 120 CHINA: HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2019–2035 (VOLUME IN BILLION UNITS) 203 TABLE 121 COLOMBIA: HEALTHCARE MARKET, BY PRODUCT, 2019–2035 (USD BILLION) 204 TABLE 122 COLOMBIA: HEALTHCARE MARKET, BY PRODUCT, 2019–2035 (VOLUME IN BILLION UNITS) 204 TABLE 123 COLOMBIA: HEALTHCARE MARKET, BY APPLICATION, 2019–2035 (USD BILLION) 205 TABLE 124 COLOMBIA: HEALTHCARE MARKET, BY APPLICATION, 2019–2035 (VOLUME IN BILLION UNITS) 207 TABLE 125 COLOMBIA: HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2019–2035 (USD BILLION) 209 TABLE 126 COLOMBIA: HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2019–2035 (VOLUME IN BILLION UNITS) 209 TABLE 127 BRAZIL: HEALTHCARE MARKET, BY PRODUCT, 2019–2035 (USD BILLION) 210 TABLE 128 BRAZIL: HEALTHCARE MARKET, BY PRODUCT, 2019–2035 (VOLUME IN BILLION UNITS) 210 TABLE 129 BRAZIL: HEALTHCARE MARKET, BY APPLICATION, 2019–2035 (USD BILLION) 211 TABLE 130 BRAZIL: HEALTHCARE MARKET, BY APPLICATION, 2019–2035 (VOLUME IN BILLION UNITS) TABLE 131 BRAZIL: HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2019–2035 (USD BILLION) TABLE 132 BRAZIL: HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2019–2035 (VOLUME IN BILLION UNITS) TABLE 133 REST OF THE WORLD COUNTRIES: HEALTHCARE MARKET, BY PRODUCT, 2019–2035 (USD BILLION) TABLE 134 REST OF THE WORLD COUNTRIES: HEALTHCARE MARKET, BY PRODUCT, 2019–2035 (VOLUME IN BILLION UNITS) TABLE 135 REST OF THE WORLD COUNTRIES: HEALTHCARE MARKET, BY APPLICATION, 2019–2035 (USD BILLION) TABLE 136 REST OF THE WORLD COUNTRIES: HEALTHCARE MARKET, BY APPLICATION, 2019–2035 (VOLUME IN BILLION UNITS) TABLE 137 REST OF THE WORLD COUNTRIES: HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2019–2035 (USD BILLION) TABLE 138 REST OF THE WORLD COUNTRIES: HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2019–2035 (VOLUME IN BILLION UNITS) 222 TABLE 139 PRODUCT LAUNCH TABLE 140 ACQUISITION/EXPANSION TABLE 141 COLLABORATION/ PARTNERSHIP TABLE 142 FACILITY EXPANSION TABLE 143 PROCTER & GAMBLE: PRODUCTS OFFERED TABLE 144 PROCTER & GAMBLE: KEY DEVELOPMENTS TABLE 145 RECKITT BENCKISER GROUP PLC : PRODUCTS OFFERED TABLE 146 RECKITT BENCKISER GROUP PLC: KEY DEVELOPMENTS TABLE 147 ABBOTT: PRODUCTS OFFERED TABLE 148 ABBOTT: KEY DEVELOPMENTS TABLE 149 BOIRON LABORATORIES: PRODUCTS OFFERED TABLE 150 GNC HOLDINGS, LLC: PRODUCTS OFFERED TABLE 151 BAYER AG: PRODUCTS OFFERED TABLE 152 BAYER AG: KEY DEVELOPMENTS TABLE 153 JOHNSON & JOHNSON INC.: PRODUCTS OFFERED TABLE 154 JOHNSON & JOHNSON INC.: KEY DEVELOPMENTS TABLE 155 UNILEVER: PRODUCTS OFFERED TABLE 156 UNILEVER: KEY DEVELOPMENTS TABLE 157 NESTLÉ: PRODUCT OFFERED TABLE 158 HALEON PLC: PRODUCT OFFERED LIST OF FIGURES FIGURE 1 GLOBAL HEALTHCARE MARKET: STRUCTURE 22 FIGURE 2 GLOBAL HEALTHCARE MARKET: MARKET GROWTH AFFECTING FACTOR ANALYSIS (2019-2035) 45 FIGURE 3 GLOBAL POPULATION AGES 65 AND ABOVE (% OF TOTAL POPULATION) 46 FIGURE 4 GLOBAL HEALTHCARE MARKET DRIVER: IMPACT ANALYSIS 48 FIGURE 5 GLOBAL HEALTHCARE MARKET RESTRAINT: IMPACT ANALYSIS 50 FIGURE 6 PORTER'S FIVE FORCES ANALYSIS: THE GLOBAL HEALTHCARE MARKET 67 FIGURE 7 GLOBAL HEALTHCARE MARKET, BY PRODUCT, 2024 & 2035 (USD MILLION) 73 FIGURE 8 GLOBAL HEALTHCARE MARKET SHARE (%), BY PRODUCT, 2024 75 FIGURE 9 GLOBAL HEALTHCARE MARKET, BY PRODUCT AND APPLICATION, 2024 & 2035 (USD MILLION) 78 FIGURE 10 GLOBAL HEALTHCARE MARKET SHARE (%), BY PRODUCT AND APPLICATION, 2024 79 FIGURE 11 GLOBAL HEALTHCARE MARKET, BY CATEGORY AND PRODUCT, 2024 & 2035 (USD MILLION) 81 FIGURE 12 GLOBAL HEALTHCARE MARKET SHARE (%), BY CATEGORY AND PRODUCT, 2024 82 FIGURE 13 GLOBAL HEALTHCARE MARKET, BY APPLICATION, 2024 & 2035 (USD MILLION) 87 FIGURE 14 GLOBAL HEALTHCARE MARKET SHARE (%), BY APPLICATION, 2024 91 FIGURE 15 GLOBAL HEALTHCARE MARKET, BY APPLICATION AND GALENIC FORMS, 2024 & 2035 (USD MILLION) 93 FIGURE 16 GLOBAL HEALTHCARE MARKET SHARE (%), BY APPLICATION AND GALENIC FORMS, 2024 94 FIGURE 17 GLOBAL HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2024 & 2035 (USD MILLION) 96 FIGURE 18 GLOBAL HEALTHCARE MARKET SHARE (%), BY DISTRIBUTION CHANNEL, 2024 97 FIGURE 19 GLOBAL HEALTHCARE MARKET, BY REGION, 2024 & 2035 (USD BILLION) 98 FIGURE 20 GLOBAL HEALTHCARE MARKET SHARE (%), BY REGION, 2024 99 FIGURE 21 NORTH AMERICA: HEALTHCARE MARKET, BY COUNTRY, 2024 & 2035 (USD BILLION) 101 FIGURE 22 NORTH AMERICA: HEALTHCARE MARKET SHARE (%), BY COUNTRY, 2024 102 FIGURE 23 EUROPE HEALTHCARE MARKET, BY REGION, 2024 & 2035 (USD BILLION) 121 FIGURE 24 EUROPE HEALTHCARE MARKET SHARE (%), BY REGION, 2024 128 FIGURE 25 REST OF THE WORLD: HEALTHCARE MARKET, BY COUNTRY, 2024 & 2035 (USD BILLION) 190 FIGURE 26 REST OF THE WORLD: HEALTHCARE MARKET SHARE (%), BY COUNTRY, 2024 192 FIGURE 27 GLOBAL HEALTHCARE MARKET PLAYERS: COMPETITIVE ANALYSIS, 2024 224 FIGURE 28 COMPETITOR DASHBOARD: GLOBAL HEALTHCARE MARKET 225 FIGURE 29 PROCTER & GAMBLE: FINANCIAL OVERVIEW SNAPSHOT 231 FIGURE 30 PROCTER & GAMBLE: SWOT ANALYSIS 235 FIGURE 31 RECKITT BENCKISER GROUP PLC: FINANCIAL OVERVIEW SNAPSHOT 238 FIGURE 32 RECKITT BENCKISER GROUP PLC : SWOT ANALYSIS 241 FIGURE 33 ABBOTT: FINANCIAL OVERVIEW SNAPSHOT 243 FIGURE 34 BOIRON LABORATORIES: FINANCIAL OVERVIEW SNAPSHOT 249 FIGURE 35 BAYER AG: FINANCIAL OVERVIEW SNAPSHOT 256 FIGURE 36 BAYER AG: SWOT ANALYSIS 259 FIGURE 37 JOHNSON & JOHNSON INC.: FINANCIAL OVERVIEW SNAPSHOT 261 FIGURE 38 UNILEVER: FINANCIAL OVERVIEW SNAPSHOT 265 SOURCE: ANNUAL REPORT, PRESS RELEASES, AND MRFR ANALYSIS 265 FIGURE 39 UNILEVER: SWOT ANALYSIS 267 FIGURE 40 NESTLÉ: FINANCIAL OVERVIEW SNAPSHOT FIGURE 41 HALEON PLC: FINANCIAL OVERVIEW SNAPSHOT FIGURE 42 HALEON PLC: SWOT ANALYSIS

提及公司

Procter & GambleReckitt Benckiser Group PlcAbbottBoiron LaboratoriesGNC HoldingsLLCBayer AGJohnson & Johnson Inc.UnileverNestléHaleon Plc

同分類最新報告（醫療與生命科學）

查看醫療與生命科學全部報告 →

量子訊息有限公司為 Market Research Future 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們